These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17172122)

  • 21. [Experimental study on induction of skin allograft tolerance in mice by heat shock protein 60].
    Huang W; Ye Q; Huang Z; Yang D; Peng M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Aug; 22(8):993-7. PubMed ID: 18773821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of Th17 cells in early onset of mice acute graft versus host disease].
    Cheng H; Zeng LY; Pan B; Song GL; Tian J; Chen C; Yan ZL; Li ZY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):322-5. PubMed ID: 21729601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
    Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
    Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
    Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association between acute graft versus host disease and lung injury after allogenic hematopoietic stem cell transplantation].
    Liu QF; Luo XD; Fan ZP; Ning J; Xu D; Sun J; Zhang Y; Xu B; Wei YQ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):538-42. PubMed ID: 19567075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease.
    Natzke AM; Shaw JL; McKeller MR; Emo KL; Mullen CA
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):34-45. PubMed ID: 17222751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe₃O₄ combined with cyclosporin A in murine models.
    Cheng J; Zhou Y; Chen B; Wang J; Xia G; Jin N; Ding J; Gao C; Chen G; Miao Y; Li W; Liu Z; Wang X
    Int J Nanomedicine; 2011; 6():2183-9. PubMed ID: 22114482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The correlated research of acute graft versus host disease after allogeneic stem cell transplantation].
    Yang F; Chen H; Liu GX; Lu M; Feng K; Zhang YG; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):264-8. PubMed ID: 16875562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
    Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of exercise interventions in graft-versus-host disease models.
    Fiuza-Luces C; González-Murillo A; Soares-Miranda L; Martínez Palacio J; Colmenero I; Casco F; Melén G; Morán M; Lucia A; Ramírez M
    Cell Transplant; 2013; 22(12):2409-20. PubMed ID: 23127525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study the mechanisms and inducing transplantation immune tolerance of FTY720].
    Zhang L; Zhu T; Sun EW; Shen SQ; Guo H; Min ZL; Chen ZH
    Zhonghua Wai Ke Za Zhi; 2003 Oct; 41(10):773-7. PubMed ID: 14766054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of bortezomib on acute graft-versus-host disease in mice model and its mechanism].
    Li ZY; Wu SH; Xu KL; Lu QX; Pan XY; Sun HY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jun; 30(6):399-403. PubMed ID: 19951534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect and mechanism of acute graft versus host disease on early diffuse murine lung injury following allogeneic stem cell transplantation.
    Ning J; Liu QF; Luo XD; Fan ZP; Zhang Y
    Sci China C Life Sci; 2009 Nov; 52(11):1016-22. PubMed ID: 19937199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
    Luo XD; Liu QF; Ning J; Wei YQ; Fan ZP; Zhang Y; Sun J
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3280-3. PubMed ID: 18396625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Allogeneic hematopoietic stem cell transplantation for 16 patients with aplastic anemia].
    Zhai WH; Wang M; Zhou Z; Zhai WJ; Zhang RL; Wang H; Song AX; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):78-82. PubMed ID: 17650665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.